Page last updated: 2024-10-18

kynurenine and Tuberous Sclerosis

kynurenine has been researched along with Tuberous Sclerosis in 2 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, H1
Shindo, I1
Egawa, B1
Horiguchi, K1
Suzuki, Y1

Other Studies

2 other studies available for kynurenine and Tuberous Sclerosis

ArticleYear
Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms.
    Pediatric neurology, 1994, Volume: 10, Issue:1

    Topics: Asphyxia Neonatorum; Brain; Chromatography, High Pressure Liquid; Electroencephalography; Female; Hu

1994
[Cytogenetic study of tuberous sclerosis].
    No to shinkei = Brain and nerve, 1977, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Chromatids; Chromosome Aberrations; Chromosomes; DNA Rep

1977